Cargando…

Hypertension and erectile dysfunction: The role of endovascular therapy in Asia

The prevalence of erectile dysfunction (ED) is above 40% in both Asian and non‐Asian male populations after the age of 40 years. The prevalence of ED among hypertensive patients is approximately double than that in normotensive population. Pelvic arterial insufficiency is the predominant cause of ED...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Tzung‐Dau, Lee, Chih‐Kuo, Chia, Yook‐Chin, Tsoi, Kelvin, Buranakitjaroen, Peera, Chen, Chen‐Huan, Cheng, Hao‐Min, Tay, Jam Chin, Teo, Boon Wee, Turana, Yuda, Sogunuru, Guru Prasad, Wang, Ji‐Guang, Kario, Kazuomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Hypertension and Clinical Outcomes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029574/ https://www.ncbi.nlm.nih.gov/pubmed/33314715 http://dx.doi.org/10.1111/jch.14123

Ejemplares similares

Hypertension in a multi‐ethnic Asian population of Singapore
por: Chan, Gek Cher, et al.
Publicado: (2020)

Characteristics of hypertension in obstructive sleep apnea: An Asian experience
por: Hoshide, Satoshi, et al.
Publicado: (2021)

Mental health problems and hypertension in the elderly: Review from the HOPE Asia Network
por: Turana, Yuda, et al.
Publicado: (2020)

Hypertension and stroke in Asia: A comprehensive review from HOPE Asia
por: Turana, Yuda, et al.
Publicado: (2020)

Hypertension and chronic kidney disease in Asian populations
por: Teo, Boon Wee, et al.
Publicado: (2021)

Angiotensin receptor neprilysin inhibitor as a novel antihypertensive drug: Evidence from Asia and around the globe
por: Lin, Donna S.‐H., et al.
Publicado: (2020)

Disaster hypertension and cardiovascular events in disaster and COVID‐19 pandemic
por: Narita, Keisuke, et al.
Publicado: (2021)

Applications of artificial intelligence for hypertension management
por: Tsoi, Kelvin, et al.
Publicado: (2021)

Dietary intervention for the management of hypertension in Asia
por: Chang, Hao‐Chih, et al.
Publicado: (2020)

Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension
por: Minh, Huynh Van, et al.
Publicado: (2021)

Long sleep duration and cardiovascular disease: Associations with arterial stiffness and blood pressure variability
por: Matsubayashi, Hideaki, et al.
Publicado: (2020)

Guidance on ambulatory blood pressure monitoring: A statement from the HOPE Asia Network
por: Kario, Kazuomi, et al.
Publicado: (2020)

Comparison of guidelines for the management of hypertension: Similarities and differences between international and Asian countries; perspectives from HOPE‐Asia Network
por: Chia, Yook‐Chin, et al.
Publicado: (2021)

The feasibility of polypill for cardiovascular disease prevention in Asian Population
por: Sukonthasarn, Apichard, et al.
Publicado: (2020)

Non‐pharmacological management of hypertension
por: Verma, Narsingh, et al.
Publicado: (2021)

Regional differences in office and self‐measured home heart rates in Asian hypertensive patients: AsiaBP@Home study
por: Tomitani, Naoko, et al.
Publicado: (2021)

Current status of adherence interventions in hypertension management in Asian countries: A report from the HOPE Asia Network
por: Shin, Jinho, et al.
Publicado: (2020)

Telemedicine in the management of hypertension: Evolving technological platforms for blood pressure telemonitoring
por: Wang, Ji‐Guang, et al.
Publicado: (2021)

The HOPE Asia network 2022 up‐date consensus statement on morning hypertension management
por: Kario, Kazuomi, et al.
Publicado: (2022)

Seven‐action approaches for the management of hypertension in Asia – The HOPE Asia network
por: Kario, Kazuomi, et al.
Publicado: (2022)

Cardiovascular risk assessment tools in Asia
por: Zhang, Yuqing, et al.
Publicado: (2022)

Role of α1‐blockers in the current management of hypertension
por: Li, Hua, et al.
Publicado: (2022)

Standardized home blood pressure monitoring: Rationale behind the 722 protocol
por: Lin, Hung‐Ju, et al.
Publicado: (2022)

Office blood pressure measurement: A comprehensive review
por: Siddique, Saulat, et al.
Publicado: (2021)

Clinical significance of nocturnal home blood pressure monitoring and nocturnal hypertension in Asia
por: Fujiwara, Takeshi, et al.
Publicado: (2021)

COVID‐19 and hypertension—evidence and practical management: Guidance from the HOPE Asia Network
por: Kario, Kazuomi, et al.
Publicado: (2020)

Insights on home blood pressure monitoring in Asia: Expert perspectives from 10 countries/regions
por: Wang, Ji‐Guang, et al.
Publicado: (2020)

Targets and management of hypertension in heart failure: focusing on the stages of heart failure
por: Miao, Huanhuan, et al.
Publicado: (2022)

Hypertensive emergencies in Asia: A brief review
por: Kotruchin, Praew, et al.
Publicado: (2022)

Differences in ambulatory blood pressure profiles between Japanese and Thai patients with hypertension /suspected hypertension
por: Tomitani, Naoko, et al.
Publicado: (2020)

The role of renal nerve stimulation in percutaneous renal denervation for hypertension: A mini‐review
por: Huang, Hui‐Chun, et al.
Publicado: (2022)

Neurodegenerative diseases and blood pressure variability: A comprehensive review from HOPE Asia
por: Turana, Yuda, et al.
Publicado: (2022)

Sleep and nocturnal hypertension: Genes, environment, and individual profiles
por: Kario, Kazuomi
Publicado: (2022)

Isolated systolic hypertension in Asia
por: Tsai, Tsung‐Ying, et al.
Publicado: (2020)

Characteristics and control of the 24‐hour ambulatory blood pressure in patients with metabolic syndrome
por: Huang, Jian‐Feng, et al.
Publicado: (2021)

Current realities of home blood pressure monitoring from physicians’ perspectives: results from Asia HBPM survey 2020
por: Wang, Tzung-Dau, et al.
Publicado: (2023)

Who should be screened for primary aldosteronism? A comprehensive review of current evidence
por: Huang, Wei‐Chieh, et al.
Publicado: (2022)

The HOPE Asia Network activity 2022: Towards better hypertension management in Asia
por: Kario, Kazuomi, et al.
Publicado: (2022)

The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg
por: Schrader, J, et al.
Publicado: (2009)

Endothelial Dysfunction in Diabetes: The role of reparatory mechanisms
por: Avogaro, Angelo, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_invf9am2dtp1c2q7e3l17tj99j